Melissa Skibba

684 total citations
21 papers, 547 citations indexed

About

Melissa Skibba is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Melissa Skibba has authored 21 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Melissa Skibba's work include Fibroblast Growth Factor Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Melissa Skibba is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Melissa Skibba collaborates with scholars based in United States, China and Macao. Melissa Skibba's co-authors include Guang Liang, Allan R. Brasier, Jie Hu, Hon Fai Chan, Jinming Zhang, Meiwan Chen, Yi Tan, Xiaokun Li, Xin Jiang and Ying Xin and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Melissa Skibba

21 papers receiving 543 citations

Peers

Countries citing papers authored by Melissa Skibba

Since Specialization

Citations

This map shows the geographic impact of Melissa Skibba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Skibba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Skibba more than expected).

Fields of papers citing papers by Melissa Skibba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Skibba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Skibba. The network helps show where Melissa Skibba may publish in the future.

Co-authorship network of co-authors of Melissa Skibba

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Skibba. A scholar is included among the top collaborators of Melissa Skibba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Skibba. Melissa Skibba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An orally bioavailable BRD4 inhibitor disrupts expansion of a pathogenic epithelial-mesenchymal niche in bleomycin-induced fibrosis 2025 ·Respiratory Research ·Melissa Skibba, Zonghui Ma, Carole L. Wilson, Zhiqing Liu, Haiying Chen, Bing Tian, (unknown), Lynn M. Schnapp, Nathan Sandbo, Jia Zhou, Allan R. Brasier	1
2	NF-κB/RelA signaling in secretoglobin progenitors mediates plasticity and MMP-induced barrier disruption in house dust mite-induced allergic asthma 2024 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Melissa Skibba, Allan R. Brasier	2
3	Genomic targets of the IRE1-XBP1s pathway in mediating metabolic adaptation in epithelial plasticity 2023 ·Nucleic Acids Research ·Dianhua Qiao, Melissa Skibba, Xiaofang Xu, Allan R. Brasier	7
4	Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis 2022 ·PubMed ·Ksenija Bernau, Melissa Skibba, (unknown), (unknown), (unknown), Yi Li, Jia Zhou, Nathan Sandbo, Allan R. Brasier	9
5	Role of Secretoglobin+ (club cell) NFκB/RelA-TGFβ signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation 2021 ·Respiratory Research ·Melissa Skibba, Xiaofang Xu, (unknown), Jan Huisken, Allan R. Brasier	8
6	Paramyxovirus replication induces the hexosamine biosynthetic pathway and mesenchymal transition via the IRE1α-XBP1s arm of the unfolded protein response 2021 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Dianhua Qiao, Melissa Skibba, Xiaofang Xu, Roberto P. Garofalo, Yingxin Zhao, Allan R. Brasier	22
7	Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis 2020 ·Frontiers in Pharmacology ·Melissa Skibba, Adam J. Drelich, Michael J. Poellmann, Seungpyo Hong, Allan R. Brasier	37
8	A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes 2018 ·Diabetologia ·Abdul H. Khan, (unknown), Melissa Skibba, Markus A. Hartmann, René Blöcher, Ewgenij Proschak, John D. Imig	37
9	Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition 2017 ·Frontiers in Pharmacology ·Melissa Skibba, Abdul H. Khan, (unknown), Michael M. Yeboah, John R. Falck, (unknown), John D. Imig	32
10	Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis 2017 ·Nephrology Dialysis Transplantation ·Michael M. Yeboah, Abdul H. Khan, Marla A. Chesnik, Melissa Skibba, (unknown), John D. Imig	8
11	iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Jinming Zhang, Jie Hu, Hon Fai Chan, Melissa Skibba, Guang Liang, Meiwan Chen	88
12	New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice 2016 ·European Journal of Pharmacology ·Melissa Skibba, Yuanyuan Qian, Yuyan Bao, Junjie Lan, Kesong Peng, Yunjie Zhao, Peng Zhong, Jie Hu, Xiaokun Li, Guang Liang	19
13	Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II 2016 ·Journal of Cellular and Molecular Medicine ·Kesong Peng, Xinqiao Tian, Yuanyuan Qian, Melissa Skibba, Chunpeng Zou, Zhiguo Liu, Jingying Wang, Zheng Xu, Xiaokun Li, Guang Liang	55
14	Inhibition of ROS and inflammation by an imidazopyridine derivative X22 attenuate high fat diet-induced arterial injuries 2015 ·Vascular Pharmacology ·Weixin Li, Lintao Wang, Weijian Huang, Melissa Skibba, Qilu Fang, (unknown), Tiemin Wei, Zhiguo Feng, Guang Liang	16
15	The Protective Effect of FGF21 on Diabetes-Induced Male Germ Cell Apoptosis Is Associated With Up-Regulated Testicular AKT and AMPK/Sirt1/PGC-1α Signaling 2015 ·Endocrinology ·Xin Jiang, Jun Chen, Chi Zhang, Zhiguo Zhang, Yi Tan, Wenke Feng, Melissa Skibba, Ying Xin, Lu Cai	51
16	Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II–Induced Kidney Fibrosis 2015 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Kang Peng, Chao Qiu, Melissa Skibba, Yuli Huang, (unknown), Yuan‐Ting Zhang, Jie Hu, Dan Liang, Chang‐Jiang Zou, (unknown), Guang Liang	26
17	A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats 2015 ·PLoS ONE ·Yuanyuan Qian, Peng Zhong, Dandan Liang, Zheng Xu, Melissa Skibba, Chunlai Zeng, Xiaokun Li, Tiemin Wei, Lianpin Wu, Guang Liang	37
18	Preventive effect of non-mitogenic acidic fibroblast growth factor on diabetes-induced testicular cell death 2014 ·Reproductive Toxicology ·Melissa Skibba, Chi Zhang, Xin Jiang, Ying Xin, Lu Cai	6
19	The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage 2013 ·PLoS ONE ·Chi Zhang, Linbo Zhang, Shali Chen, Biao Feng, Xuemian Lu, Yang Bai, Guang Liang, Yi Tan, Minglong Shao, Melissa Skibba, Litai Jin, Xiaokun Li, Subrata Chakrabarti, Lu Cai	43
20	The Roles of Fibroblast Growth Factors in the Testicular Development and Tumor 2013 ·Journal of Diabetes Research ·Xin Jiang, Melissa Skibba, Chi Zhang, Yi Tan, Ying Xin, Yaqin Qu	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact